$ATXI 4 SEC Filings

Filed On	Filing
06 Jan 2026	Form 4: Fortress Biotech, Inc., 10% owner Received 111,209 shares as a grant or award
02 Apr 2025	Form 4: Fortress Biotech, Inc., 10% owner Received 33,724 shares as a grant or award
03 Dec 2024	Form 4: Herskowitz Neil, Director Sold 23 shares ($46)
07 Nov 2024	Form 4: Kranzler Jay D, Director Sold 61 shares ($137)
01 Oct 2024	Form 4: Kranzler Jay D, Director Bought 3 shares ($7.2) · Bought 497 shares ($1.24K)
25 Sep 2024	Form 4: Rosenwald Lindsay A Md, Director Granted 30,000 Employee stock option (right to buy)
25 Sep 2024	Form 4: Herskowitz Neil, Director Granted 30,000 Employee stock option (right to buy)
25 Sep 2024	Form 4: Oltmans Curtis Gale, Director Granted 30,000 Employee stock option (right to buy)
25 Sep 2024	Form 4: MacLean Alexandra, Director Received 170,000 shares as a grant or award
25 Sep 2024	Form 4: Kranzler Jay D, Director Granted 30,000 Employee stock option (right to buy)
25 Sep 2024	Form 4: Jin David, Interim PFO and COO Received 65,000 shares as a grant or award
25 Sep 2024	Form 4: Charles Faith L., Director Granted 30,000 Employee stock option (right to buy)
17 Apr 2024	Form 4: Fortress Biotech, Inc., 10% owner Received 413,507 shares as a grant or award
03 Jan 2024	Form 4: Fortress Biotech, Inc., 10% owner Received 2,101,496 shares as a grant or award
13 Dec 2023	Form 4: Davidow Robert L, 10% owner Sold 617,000 shares ($86.6K)
12 Sep 2023	Form 4: Rosenwald Lindsay A Md, Director Bought 348,675 shares ($251K)
12 Sep 2023	Form 4: Fortress Biotech, Inc., 10% owner Bought 418,410 shares ($301K)
05 Jul 2023	Form 4: Charles Faith L., Director Granted 100,000 Employee stock option (right to buy)
05 Jul 2023	Form 4: Jin David, Interim PFO and COO Granted 250,000 Employee stock option (right to buy)
05 Jul 2023	Form 4: Rosenwald Lindsay A Md, Director Granted 100,000 Employee stock option (right to buy)

Comments